Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-03-31 @ 5:21 AM
Study NCT ID:
NCT07414394
Status:
RECRUITING
Last Update Posted:
2026-03-25
First Post:
2026-02-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tigulixostat (IBI128) vs Febuxostat in Gout
Sponsor:
Innovent Biologics Technology Limited (Shanghai R&D Center)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Gout | View |
Keywords: